National Childhood Cancer Organization Announces Annual Funding

Primary tabs

National Childhood Cancer Organization Announces Annual Funding

Rally Foundation for Childhood Cancer Research Distributes $1 Million to Support Pediatric Cancer Research Projects Nationwide
tweet me:
National Childhood Cancer Organization Announces Annual Funding #CSR
Wednesday, April 3, 2013 - 9:00am

CONTENT: Press Release

ATLANTA, April 3, 2013 /3BL Media/ PRNewswire/ -- Rally Foundation for Childhood Cancer Research (Rally), a national non-profit organization, has announced its annual funding allocation for 2013. For the first time in the organization's seven year history, Rally will be giving away more than $1 million to 23 hospitals across the country.

Rally and its medical advisory board, consisting of leading childhood cancer researchers from across the nation, award grants through a competitive peer review process assuring that the best research is funded. All grants are made in honor or memory of a Rally Kid, a child who has fought or is currently fighting cancer. Rally believes that the battle to find a cure for childhood cancers begins with a story and Rally Kids give a face and a personal story to childhood cancer.

"We are absolutely thrilled to be giving away $1 million in 2013," said Dean Crowe, Founder and CEO of Rally. "This is a major milestone for Rally as we work toward closing the childhood cancer research funding gap so that no parent ever has to hear that their child has cancer."

Highlights of Rally's 2013 grants include:

  • Dr. Jinu Abraham, Oregon Health and Sciences, Portland, Ore., Sarcoma and Brain Tumors
  • Dr. Peter Adamson, Children's Oncology Group, Arcadia, Calif., EveryChild Initiative
  • Dr. Vidya Gopalakrishnan, University of Texas MD Anderson Cancer Center, Houston, Medulloblastoma (brain tumor)
  • Dr. Shuning He, Dana-Farber Cancer Institute, Boston, Neuroblastoma (soft tissue cancer)
  • Dr. Xiofeng Wang, Dana-Farber Cancer Institute, Boston, Epigentics
  • Dr. Jason Yustein, Baylor College of Medicine, Houston, Osteosarcoma (bone cancer)
  • Dr. John Crispino, Northwestern University, Chicago, DS-ALL (leukemia in Down syndrome children)
  • Dr. Gregory Friedman, University of Alabama at Birmingham, Birmingham, Ala., Medulloblastoma (brain tumor)
  • Dr. Scott Borinstein, Vanderbilt University Medical Center, Nashville, Tenn., Ewings Sarcoma (bone cancer)
  • Dr. Simone Sredni, Ann and Robert H. Laurie Children's Hospital of Chicago, Chicago, AT/RT (brain cancer)
  • Dr. Dai Chung, Vanderbilt University Medical Center, Nashville, Tenn., Neuroblastoma (soft tissue cancer)
  • Dr. Natia Esiashvili, Emory University Medical Center, Atlanta, Survivorship
  • Dr. Rachel Kobos, Memorial Sloan Kettering Cancer Center, New York, Wilm's Tumor (kidney cancer)
  • Dr. Marta Sanchez-Martin, Columbia University Medical Center, New York, T-Cell ALL (leukemia)
  • Dr. Daniel Lacorazza, Baylor College of Medicine, Houston, ALL
  • Dr. Courtney Crane, Seattle Children's Hospital, Seattle, Brain Tumor
  • Dr. Saro Armenian, Beckman Research Institute City of Hope, Los Angeles, Survivorship partnering with Leukemia Lymphoma Society
  • Dr. David Loeb, John Hopkins University, Baltimore, Sarcomas (bone and soft tumors)

"This year's grant recipients have very promising proposals that could lead to significant scientific and translational discoveries," said Dr. Dai Chung, chair of the Rally Medical Advisory Board and Professor of Surgery at Vanderbilt Children's Hospital in Nashville, Tenn. "We look forward to seeing the progress that they will make this year as a result of receiving a Rally research grant."

"Rally's generous support for childhood cancer research has allowed us to gain a better understanding of how and why children develop cancers," said Dr. Vidya Gopalakrishnan, Associate Professor of Pediatrics Research and Molecular and Cellular Oncology at MD Anderson Cancer Center in Houston. "We now know that not all tumors are biologically equal.  Rally's 2013 grant will allow us time to apply this knowledge to personalize treatment approaches to target each child's tumor in a unique way."    

Many people are unaware that children get different kinds of cancers than adults. Despite childhood cancer being the No. 1 disease killer of children ages 0-15 in the United States, childhood cancer is severely underfunded each year.

Since its founding in 2005, Rally has distributed more than $4 million to more than 75 childhood cancer research projects nationwide, including basic science, fellowships and clinical trials.

Rally is recognized with the Independent Charities Seal of Excellence for being a leader in efficiency among non-profits. For every dollar Rally receives, 93 cents goes to support childhood cancer research, according to independently audited financials. To find out more about Rally, visit

About Rally Foundation for Childhood Cancer Research (Rally)
Childhood cancer is the number one disease killer of kids ages 0 to 15. Rally, a 501(c)(3) non-profit organization based in Atlanta, empowers volunteers across the country to raise awareness and funds for childhood cancer research to find better treatments with fewer long-term side effects and, ultimately, cure. Volunteers participate in the Rally Athlete program, which offers half marathon training teams for select national races and other Rally fundraisers. Rally received the Independent Charities Seal of Excellence, and according to independently audited financials, 93 cents of every dollar raised, supports Rally's mission. For more information, visit

Copyright 2012 PR Newswire.  All Rights Reserved